Growth patterns of patients with 1p36 deletion syndrome.

Congenit Anom (Kyoto)

Department of Oral and Maxillofacial Surgery, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan; Institute for Integrated Medical Sciences, Tokyo Women's Medical University, Tokyo, Japan.

Published: May 2014

1p36 deletion syndrome is one of the most common subtelomeric deletion syndromes. Obesity is frequently observed in patients with this syndrome. Thus, it is important to evaluate the growth status of an individual patient. For this purpose, we accumulated recorded growth data from 44 patients with this syndrome and investigated the growth patterns of patients. Most of the patients showed weight parameters within normal limits, whereas a few of these patients showed intrauterine growth delay and microcephaly. The length of the patients after birth was under the 50th centile in most patients. Many patients showed poor weight gain after birth, and only two female patients were overweight. These findings indicate two different phenotypes of the 1p36 deletion syndrome. The overweight patients with 1p36 deletion started excessive weight gain after two years of life. This characteristic of the patients with 1p36 deletion syndrome is similar to Prader-Willi syndrome.

Download full-text PDF

Source
http://dx.doi.org/10.1111/cga.12029DOI Listing

Publication Analysis

Top Keywords

1p36 deletion
20
deletion syndrome
16
patients
12
patients 1p36
12
growth patterns
8
patterns patients
8
patients syndrome
8
patients patients
8
weight gain
8
syndrome
7

Similar Publications

Background: Segmental chromosome aberrations, defined as presence of aberrations, deletion, or imbalance in the chromosomal arms, have long been considered as a predictor of poor prognosis of patients with neuroblastoma. The objective of this meta-analysis is to quantitively analyze the hazard ratios (HRs) of different whole or segmental chromosome aberrations for overall survival (OS) rate or event-free survival (EFS) rate of patients with neuroblastoma.

Methods: Relevant studies about chromosome, neuroblastoma, predictor, prognosis, and survival published from the inception to April 2023 in the databases of PubMed, Embase, and Web of Science were searched, screened, and reviewed.

View Article and Find Full Text PDF
Article Synopsis
  • A case study discussed the use of expanded non-invasive prenatal testing (NIPT) to detect 1p36 deletion syndrome in a 37-year-old woman undergoing pregnancy via in vitro fertilization.* -
  • The NIPT was positive for a genetic issue at 13 weeks, but tragically, the pregnancy ended with intrauterine fetal death after a follow-up amniocentesis, which confirmed chromosomal abnormalities.* -
  • The findings highlight the efficacy of NIPT for early detection of genetic disorders, specifically familial unbalanced reciprocal translocation, which can aid in prenatal genetic counseling.*
View Article and Find Full Text PDF

In the monosomy 1p36 deletion syndrome, the role of DNA methylation in the genomic stability of the 1p36 region remains elusive. We hypothesize that changes in the methylation pattern at the 1p36 breakpoint hotspot region influenced the chromosomal breakage leading to terminal deletions. From the monosomy 1p36 material collection, four cases with 4.

View Article and Find Full Text PDF

Background: Glioma is a highly heterogeneous and poorly immunogenic malignant tumor, with limited efficacy of immunotherapy. The characteristics of the immunosuppressive tumor microenvironment (TME) are one of the important factors hindering the effectiveness of immunotherapy. Therefore, this study aims to reveal the immune microenvironment (IME) characteristics of glioma and predict different immune subtypes using machine learning methods, providing guidance for immune therapy in glioma.

View Article and Find Full Text PDF

Radio-Tartaglia syndrome (RATARS) (MIM#619312) is a genetic disorder caused by heterozygous truncating variants of SPEN on chromosome 1p36. This syndrome is extremely rare, with only 34 cases reported to date. RATARS is characterized by developmental delay, hypotonia, and intellectual disability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!